Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
  1. Home
  3. Family Caregiving For Individuals With Heart Failure: A Scientific Statement From The American Heart Association.
  1. Home
  3. Family Caregiving For Individuals With Heart Failure: A Scientific Statement From The American Heart Association.

Related Experiment Video

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

10.1K

Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association.

Lisa Kitko, Colleen K McIlvennan, Julie T Bidwell

    Circulation
    |May 1, 2020

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Caregivers provide essential support for individuals with heart failure (HF), managing increasingly complex medical needs. Understanding and supporting these unpaid caregivers is crucial for improving patient outcomes and caregiver well-being.

    Keywords:
    AHA Scientific Statementsfamily caregiversheart failure

    More Related Videos

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.4K
    Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
    08:07

    Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

    Published on: April 28, 2023

    1.9K

    Related Experiment Videos

    An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
    07:15

    An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

    Published on: July 31, 2019

    10.1K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.4K
    Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
    08:07

    Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

    Published on: April 28, 2023

    1.9K

    Area of Science:

    • Cardiology
    • Gerontology
    • Public Health

    Background:

    • Heart failure (HF) caregiving involves unpaid support from family and friends.
    • Caregiving tasks have intensified due to medical advancements for HF patients.
    • Caregiver roles vary based on patient condition, relationship, and treatment complexity.

    Purpose of the Study:

    • To characterize the evolving role of heart failure caregivers.
    • To describe the multifaceted implications of caregiving for both caregiver and patient.
    • To evaluate interventions, policies, and resources supporting heart failure caregivers.

    Main Methods:

    • This scientific statement synthesizes existing evidence on heart failure caregiving.
    • It analyzes the changing nature of caregiving responsibilities throughout the illness trajectory.
  • The review examines financial, health, and well-being impacts, alongside interventions and policy.

    • Main Results:

    • Caregiving for heart failure patients involves diverse and intensive tasks.
    • Caregiving significantly impacts the physical, psychological, and financial well-being of caregivers.
    • Existing interventions and policies offer partial support but knowledge gaps remain.

    Conclusions:

    • Understanding and supporting heart failure caregivers is critical for patient and caregiver well-being.
    • Further research and policy development are needed to address the complex needs of these caregivers.
    • Enhanced support systems are essential for the sustainability of heart failure caregiving.